Nov 5 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 740 mln 174 mln 1.90
(+324.5 pct) (-44.4 pct) (+90.7 pct)
Operating loss 450 mln loss 682 mln loss 1.72
Recurring loss 463 mln loss 693 mln loss 1.74
Net loss 463 mln loss 696 mln loss 1.32
EPS loss 15.30 yen loss 24.49 yen loss 42.91 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T